Earlier this year the Indian Patent Office updated a number of rules to “address some of the major pain points experienced by the patent applicants in Indian patent procedure”. These include everyone’s favourite procedural requirements: filing annual working statements and periodically submitting the details and prosecution documents issued on corresponding foreign patent applications. Some of the key changes are summarised below.
Last Friday, 19th July 2024, the Court of Appeal handed down a highly anticipated decision in the case between the Comptroller General of Patents, Designs and Trade Marks (Comptroller) and Emotional Perception AI Ltd (EPL) [2024] EWCA Civ 825. This decision should provide greater clarity on the patentability in the UK of inventions using AI.
On 2 May 2024, the Paris Central Division of the UPC issued a decision concerning the jurisdiction and the applicability of the Brussels I Regulation (recast) in the context of a patent revocation action brought before the UPC. In the ongoing revocation action brought by Nokia Technology GmbH against Mala Technologies Ltd., a preliminary objection filed by Mala Technologies required the UPC to examine its relationship with the national courts of member states.
For those who read my recent article which discussed the value of the aerospace sector to the UK economy, you will know that there are certainly green shoots of recovery in the sector after the trials of the pandemic.
One of the defining features of modern life is consumer electronics. Smart devices with computational power that would have been staggering a few decades ago are now so commonplace that they’re completely taken for granted, and many people are never without their smartphone.
Tune in and listen to Aimava's Andrew Gaule discussing with Simon Portman, of Counsel, Marks and Clerk, IP and the legal challenges required to ensure the most is made of IP.
There has been a spattering of case law over the last few years concerned with clinical trial proposals as prior art for patent applications. The status of clinical trial proposals as prior art is particularly relevant to patent applications relating to medical products and medical uses, and this issue has recently been of relevance to one of our clients’ patents.
UK economic growth over the last few years has been lacklustre. With growth of only 1.7% compared to pre-pandemic levels, the UK’s growth has been the second-lowest in the G7 and behind the US and France, with only Germany having lower growth over this period. In addition, the UK’s productivity, i.e. economic output per hour worked, has remained stubbornly flat over the last few years, while the US, France and Germany have stretched their lead in productivity levels.
In the latest Dead Cat Live Cat interview with Quantum specialists, host Rhian Granleese, Partner at Marks & Clerk, interviews guest Lene B. Oddershede, Senior Vice President at the Novo Nordisk Foundation.